‘Emergency’ COVID-19 Vaccine May Be Ready by September

‘Emergency’ COVID-19 Vaccine May Be Ready by September

China could have a vaccine for use by healthcare workers in an “emergency situation” from the new coronavirus next September. This was reported, according to local media, the director of the Center for Disease Control and Prevention in that country, Gao Fu.

It comes as health experts say the coronavirus is mutating at a slower rate than several other respiratory viruses, particularly the flu.

“Perhaps in September we could have a vaccine to be used in an emergency…And it will be applied by specialist groups such as the healthcare workers, Gao said in an interview with the international channel of Chinese State television.

He estimated that at the beginning of next year the antidote candidates with whom he rehearses China they would be ready to use in healthy people. However, he warned that everything will depend on the evolution of the research and development process.

Also, he indicated that in the Asian country there are two “aspiring” vaccines under clinical trials. One is an adenovirus vector vaccine; the other is an inactivated cure, both in the second phase of clinical experimentation. Usually the period to be available is between 12 and 18 months, at least, according to the World Health Organization.

However, due to scientific development and the urgency of the current situation, the former could be provided to health workers for “emergency” use, said Gao, who insisted that the massive use would take a few more months.

China is testing up to five options vaccines, and the two whose clinical trials have entered the second phase and are developed by the Wuhan Institute of Biological Products of the Chinese National Pharmaceutical Group and a laboratory in Beijing of the Sinovac Biotech company.